DEFICIENCY OF ADAMTS-13 IN SEPSIS PATIENTS AND ITS CORRELATION WITH MORBIDITY/ MORTALITY

Objective: To detect ADAMTS-13 deficiency in sepsis patients and its effect on in-hospital morbidity and mortality in adult patients of sepsis. Study Design: Cross sectional study. Place and Duration of Study: Armed Forces Institute of Pathology (AFIP) and Combined Military Hospital (CMH) Rawa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Syed Owais Ali, Chaudhry Altaf Hussain, Dawood Ahmad, Rafia Mahmood, Syeda Sarwat Fatima, Taqdees Fatima
Formato: article
Lenguaje:EN
Publicado: Army Medical College Rawalpindi 2021
Materias:
R
Acceso en línea:https://doi.org/10.51253/pafmj.v71iSuppl-1.6210
https://doaj.org/article/31d4ef9cc276413cb4b3d3aec0a74b81
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:31d4ef9cc276413cb4b3d3aec0a74b81
record_format dspace
spelling oai:doaj.org-article:31d4ef9cc276413cb4b3d3aec0a74b812021-12-02T17:18:43ZDEFICIENCY OF ADAMTS-13 IN SEPSIS PATIENTS AND ITS CORRELATION WITH MORBIDITY/ MORTALITYhttps://doi.org/10.51253/pafmj.v71iSuppl-1.62100030-96482411-8842https://doaj.org/article/31d4ef9cc276413cb4b3d3aec0a74b812021-01-01T00:00:00Zhttps://pafmj.org/index.php/PAFMJ/article/view/6210https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To detect ADAMTS-13 deficiency in sepsis patients and its effect on in-hospital morbidity and mortality in adult patients of sepsis. Study Design: Cross sectional study. Place and Duration of Study: Armed Forces Institute of Pathology (AFIP) and Combined Military Hospital (CMH) Rawalpindi, from Apr 2017 to Apr 2018. Methodology: All indoor patients admitted at Combined Military Hospital Rawalpindi and diagnosed as suffering from sepsis at Armed Forces Institute of Pathology according to the guidelines of the Critical Care Society of Medicine Consensus Conference Committee. Forty sepsis patients were recruited for the study. Two groups were formed on the basis of ADAMTS-13 antigen levels, non-deficient and deficient. Basic haematological and clinical parameters were recorded. Levels of ADAMTS-13 antigen were analyzed by using Technozyme kit byenzyme-linked immunosorbent assay (ELISA) and level less than 0.40 IU/ml was taken deficient as defined by manufacturer. Comparison was done between ADAMTS-13 deficient and non-deficient group with regard to clinical and haematological characteristics, ICU stay, hospital admission days and in-hospital mortality. Healthy controls of same age and gender were also observed for ADAMTS-13 antigen level. Results: Among total 40 sepsis patients, thirty two (80%) were males and eight (20%) were females with a mean age of 61 ± 15 years (range: 30-85 years). ADAMTS-13 deficiency (<0.40 IU/ml) was found in 28 (70%) of patients while 12 (30%) had normal antigen levels. In patients with ADAMTS-13 deficiency, twenty four (85.7%) had low platelet levels <150 x 109/l, mean hospital stay 19.2 ± 7.6 days and in-hospital mortality was seen in eight (28.6%) patients, in comparison of non-deficient group in which platelet levels were equal or >150 x 109/l, mean hospital stay was 10.2 ± 3.6 days and in-hospital mortality was in one (8.3%) patient respectively. ADAMTS-13 antigen level was found sufficient in healthy controls. Conclusion: Majority of the sepsis patients were found ADAMTS-13 deficient. Deficiency exhibit long term hospital admission, thrombocytopenia and increase in hospital mortality. ADAMTS-13 deficiency might play a role in sepsis induced thrombocytopenia and in hospital mortality. More studies are recommended on the subject with larger sample size to evaluate its role in sepsisSyed Owais AliChaudhry Altaf HussainDawood AhmadRafia MahmoodSyeda Sarwat FatimaTaqdees FatimaArmy Medical College Rawalpindiarticlea disintegrin and metalloprotease with a thrombospondin type1 motifmember 13disseminated intravascular coagulationenzyme-linked immunosorbent assaythrombotic thrombocytopenic purpuraMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 71, Iss SUPPL-1, Pp 158-163 (2021)
institution DOAJ
collection DOAJ
language EN
topic a disintegrin and metalloprotease with a thrombospondin type1 motif
member 13
disseminated intravascular coagulation
enzyme-linked immunosorbent assay
thrombotic thrombocytopenic purpura
Medicine
R
Medicine (General)
R5-920
spellingShingle a disintegrin and metalloprotease with a thrombospondin type1 motif
member 13
disseminated intravascular coagulation
enzyme-linked immunosorbent assay
thrombotic thrombocytopenic purpura
Medicine
R
Medicine (General)
R5-920
Syed Owais Ali
Chaudhry Altaf Hussain
Dawood Ahmad
Rafia Mahmood
Syeda Sarwat Fatima
Taqdees Fatima
DEFICIENCY OF ADAMTS-13 IN SEPSIS PATIENTS AND ITS CORRELATION WITH MORBIDITY/ MORTALITY
description Objective: To detect ADAMTS-13 deficiency in sepsis patients and its effect on in-hospital morbidity and mortality in adult patients of sepsis. Study Design: Cross sectional study. Place and Duration of Study: Armed Forces Institute of Pathology (AFIP) and Combined Military Hospital (CMH) Rawalpindi, from Apr 2017 to Apr 2018. Methodology: All indoor patients admitted at Combined Military Hospital Rawalpindi and diagnosed as suffering from sepsis at Armed Forces Institute of Pathology according to the guidelines of the Critical Care Society of Medicine Consensus Conference Committee. Forty sepsis patients were recruited for the study. Two groups were formed on the basis of ADAMTS-13 antigen levels, non-deficient and deficient. Basic haematological and clinical parameters were recorded. Levels of ADAMTS-13 antigen were analyzed by using Technozyme kit byenzyme-linked immunosorbent assay (ELISA) and level less than 0.40 IU/ml was taken deficient as defined by manufacturer. Comparison was done between ADAMTS-13 deficient and non-deficient group with regard to clinical and haematological characteristics, ICU stay, hospital admission days and in-hospital mortality. Healthy controls of same age and gender were also observed for ADAMTS-13 antigen level. Results: Among total 40 sepsis patients, thirty two (80%) were males and eight (20%) were females with a mean age of 61 ± 15 years (range: 30-85 years). ADAMTS-13 deficiency (<0.40 IU/ml) was found in 28 (70%) of patients while 12 (30%) had normal antigen levels. In patients with ADAMTS-13 deficiency, twenty four (85.7%) had low platelet levels <150 x 109/l, mean hospital stay 19.2 ± 7.6 days and in-hospital mortality was seen in eight (28.6%) patients, in comparison of non-deficient group in which platelet levels were equal or >150 x 109/l, mean hospital stay was 10.2 ± 3.6 days and in-hospital mortality was in one (8.3%) patient respectively. ADAMTS-13 antigen level was found sufficient in healthy controls. Conclusion: Majority of the sepsis patients were found ADAMTS-13 deficient. Deficiency exhibit long term hospital admission, thrombocytopenia and increase in hospital mortality. ADAMTS-13 deficiency might play a role in sepsis induced thrombocytopenia and in hospital mortality. More studies are recommended on the subject with larger sample size to evaluate its role in sepsis
format article
author Syed Owais Ali
Chaudhry Altaf Hussain
Dawood Ahmad
Rafia Mahmood
Syeda Sarwat Fatima
Taqdees Fatima
author_facet Syed Owais Ali
Chaudhry Altaf Hussain
Dawood Ahmad
Rafia Mahmood
Syeda Sarwat Fatima
Taqdees Fatima
author_sort Syed Owais Ali
title DEFICIENCY OF ADAMTS-13 IN SEPSIS PATIENTS AND ITS CORRELATION WITH MORBIDITY/ MORTALITY
title_short DEFICIENCY OF ADAMTS-13 IN SEPSIS PATIENTS AND ITS CORRELATION WITH MORBIDITY/ MORTALITY
title_full DEFICIENCY OF ADAMTS-13 IN SEPSIS PATIENTS AND ITS CORRELATION WITH MORBIDITY/ MORTALITY
title_fullStr DEFICIENCY OF ADAMTS-13 IN SEPSIS PATIENTS AND ITS CORRELATION WITH MORBIDITY/ MORTALITY
title_full_unstemmed DEFICIENCY OF ADAMTS-13 IN SEPSIS PATIENTS AND ITS CORRELATION WITH MORBIDITY/ MORTALITY
title_sort deficiency of adamts-13 in sepsis patients and its correlation with morbidity/ mortality
publisher Army Medical College Rawalpindi
publishDate 2021
url https://doi.org/10.51253/pafmj.v71iSuppl-1.6210
https://doaj.org/article/31d4ef9cc276413cb4b3d3aec0a74b81
work_keys_str_mv AT syedowaisali deficiencyofadamts13insepsispatientsanditscorrelationwithmorbiditymortality
AT chaudhryaltafhussain deficiencyofadamts13insepsispatientsanditscorrelationwithmorbiditymortality
AT dawoodahmad deficiencyofadamts13insepsispatientsanditscorrelationwithmorbiditymortality
AT rafiamahmood deficiencyofadamts13insepsispatientsanditscorrelationwithmorbiditymortality
AT syedasarwatfatima deficiencyofadamts13insepsispatientsanditscorrelationwithmorbiditymortality
AT taqdeesfatima deficiencyofadamts13insepsispatientsanditscorrelationwithmorbiditymortality
_version_ 1718381077797535744